-
5-butyl-5-ethyl-1,3-diazinane-2,4,6-trione
-
ChemBase ID:
1181
-
Molecular Formular:
C10H16N2O3
-
Molecular Mass:
212.24564
-
Monoisotopic Mass:
212.11609238
-
SMILES and InChIs
SMILES:
O=C1NC(=O)NC(=O)C1(CCCC)CC
Canonical SMILES:
CCCCC1(CC)C(=O)NC(=O)NC1=O
InChI:
InChI=1S/C10H16N2O3/c1-3-5-6-10(4-2)7(13)11-9(15)12-8(10)14/h3-6H2,1-2H3,(H2,11,12,13,14,15)
InChIKey:
STDBAQMTJLUMFW-UHFFFAOYSA-N
-
Cite this record
CBID:1181 http://www.chembase.cn/molecule-1181.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
5-butyl-5-ethyl-1,3-diazinane-2,4,6-trione
|
|
|
IUPAC Traditional name
|
|
Brand Name
|
Etoval
|
Hyperbutal
|
Longanoct
|
Meonal
|
Monodorm
|
Neonal
|
Sonerile
|
Soneryl
|
Budorm
|
|
|
Synonyms
|
Butethal
|
5-n-Butyl-5-ethylbarbituric Acid
|
Budorm
|
Etoval
|
Hyperbutal
|
Longanoct
|
Monodorm
|
NSC 229336
|
Neonal
|
Sonerile
|
Soneryl
|
Butobarbital
|
Butobarbital
|
5-Butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione
|
5-Butyl-5-ethylbarbituric acid
|
Butobarbitone
|
5-Ethyl-5-butylbarbituric acid
|
5-Ethyl-5-N-butylbarbituric acid
|
Butabarbitol
|
Butobarbitalum
|
Butobarbitural
|
Butyl,5-ethylbarbituric acid
|
Butethal
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
TRC
|
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
Acid pKa
|
8.48475
|
H Acceptors
|
3
|
H Donor
|
2
|
LogD (pH = 5.5)
|
1.6057878
|
LogD (pH = 7.4)
|
1.5723026
|
Log P
|
1.6062322
|
Molar Refractivity
|
53.4543 cm3
|
Polarizability
|
20.98239 Å3
|
Polar Surface Area
|
75.27 Å2
|
Rotatable Bonds
|
4
|
Lipinski's Rule of Five
|
true
|
Log P
|
1.65
|
LOG S
|
-2.22
|
Solubility (Water)
|
1.27e+00 g/l
|
PROPERTIES
PROPERTIES
Physical Property
Safety Information
Product Information
Bioassay(PubChem)
Solubility
|
4.88 mg/mL at 25 oC [YALKOWSKY,SH & DANNENFELSER,RM (1992)]
|
Show
data source
|
|
Hydrophobicity(logP)
|
1.73 [HANSCH,C ET AL. (1995)]
|
Show
data source
|
|
DETAILS
DETAILS
DrugBank
TRC
DrugBank -
DB01353
|
Item |
Information |
Drug Groups
|
illicit; approved |
Description
|
Butethal is a sedative and a hypnotic drug. |
Indication |
For the treatment of insomnia. |
Pharmacology |
Butethal (also known as butobarbitone and butobarbital) belongs to a group of medicines called the barbiturates. It is thought to act on receptors in the brain (GABA receptors) causing the release of the chemical GABA. This chemical inhibits certain areas of the brain resulting in sleepiness. |
Toxicity |
Signs of overdose include confusion (severe), decrease in or loss of reflexes, drowsiness (severe), fever, irritability (continuing), low body temperature, poor judgment, shortness of breath or slow or troubled breathing, slow heartbeat, slurred speech, staggering, trouble in sleeping, unusual movements of the eyes, weakness (severe). |
Affected Organisms |
• |
Humans and other mammals |
|
Biotransformation |
Hepatic. |
Absorption |
Rapidly absorbed following oral administration. |
Half Life |
37 hours |
External Links |
|
|
Toronto Research Chemicals -
B690105
|
Butobarbital is a barbiturate derivative that is used as a hypnotic agent with sedative and anticonvulsant properties. Butobarbital is a Controlled Substance. |
PATENTS
PATENTS
PubChem Patent
Google Patent